The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic role of T3/T4 ratio in metastatic renal cell carcinoma (mRCC): Preliminary results of the threeFOUR multicenter study (Meet-Uro 14).
 
Marco Maruzzo
No Relationships to Disclose
 
Elena Verzoni
Consulting or Advisory Role - Janssen Oncology; Pfizer
Speakers' Bureau - Ipsen; Novartis
 
Francesco Pierantoni
No Relationships to Disclose
 
Luca Galli
No Relationships to Disclose
 
Francesca Vignani
No Relationships to Disclose
 
Sebastiano Buti
No Relationships to Disclose
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Elisa Zanardi
No Relationships to Disclose
 
Andrea Sbrana
No Relationships to Disclose
 
Giuseppe Procopio
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer
 
Andrea Zivi
No Relationships to Disclose
 
Teresa Zielli
No Relationships to Disclose
 
Enrico Mini
No Relationships to Disclose
 
Giandomenico Roviello
No Relationships to Disclose
 
Umberto Basso
No Relationships to Disclose
 
Vittorina Zagonel
No Relationships to Disclose